These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Exsanguination in trauma: A review of diagnostics and treatment options. Geeraedts LM; Kaasjager HA; van Vugt AB; Frölke JP Injury; 2009 Jan; 40(1):11-20. PubMed ID: 19135193 [TBL] [Abstract][Full Text] [Related]
46. [Changes in the pathobiochemical reactions in traumatic-hemorrhagic shock following therapy with blood substitutes based on perfluorocarbon]. Reichelt H; Hoffmann G; Lederer S; Kretschmar KH Z Med Lab Diagn; 1989; 30(1):53-5. PubMed ID: 2718580 [No Abstract] [Full Text] [Related]
47. [Circulating blood plasma proteins during the infusion therapy of blood loss]. Movshev BE; Markova ML; Kurbanova GN Patol Fiziol Eksp Ter; 1990; (3):40-3. PubMed ID: 2399039 [TBL] [Abstract][Full Text] [Related]
48. [Current state of pathophysiology and therapy of shock]. Langanke B Dtsch Stomatol; 1972 Apr; 22(4):296-303. PubMed ID: 4113264 [No Abstract] [Full Text] [Related]
49. Pulse pressure respiratory variation as an early marker of cardiac output fall in experimental hemorrhagic shock. Westphal G; Garrido Adel P; de Almeida DP; Rocha e Silva M; Poli-de-Figueiredo LF Artif Organs; 2007 Apr; 31(4):284-9. PubMed ID: 17437497 [TBL] [Abstract][Full Text] [Related]
50. [Blood and blood derivatives in the treatment of infants and older children. II]. Ochocka M Pediatr Pol; 1984 Oct; 59(10):873-80. PubMed ID: 6398423 [No Abstract] [Full Text] [Related]
51. [Hemotherapy of hemorrhagic shock]. Benad G Z Arztl Fortbild (Jena); 1972 Apr; 66(8):395-9. PubMed ID: 5046406 [No Abstract] [Full Text] [Related]
52. [Effectiveness of transfusions of autologous blood and blood substitutes in experimental hemorrhagic shock]. Levin GS; Baĭdullaev ShT Gematol Transfuziol; 1987 Jul; 32(7):41-5. PubMed ID: 2444488 [No Abstract] [Full Text] [Related]
53. Perflubron emulsion improves hepatic microvascular integrity and mitochondrial redox state after hemorrhagic shock. Paxian M; Keller SA; Huynh TT; Clemens MG Shock; 2003 Nov; 20(5):449-57. PubMed ID: 14560110 [TBL] [Abstract][Full Text] [Related]
54. [Hemorrhage and blood replacement. 1. Pathophysiology of hemorrhage, clinical picture and diagnostic measures]. Schricker KT Fortschr Med; 1981 Mar; 99(10):335-8. PubMed ID: 7216098 [No Abstract] [Full Text] [Related]
55. Bovine polymerized hemoglobin versus Hextend resuscitation in a swine model of severe controlled hemorrhagic shock with delay to definitive care. Rice J; Philbin N; McGwin G; Arnaud F; Johnson T; Flournoy WS; Pearce LB; McCarron R; Kaplan L; Handrigan M; Freilich D Shock; 2006 Sep; 26(3):302-10. PubMed ID: 16912657 [TBL] [Abstract][Full Text] [Related]
56. [Introduction to the treatment of hemorrhagic syndromes by transfusion of blood or its derivatives]. SOULIER JP Rev Pathol Gen Physiol Clin; 1954 Feb; 54(655):277-81. PubMed ID: 13167975 [No Abstract] [Full Text] [Related]
57. [Transfusion therapy in severe mechanical injuries]. Alagova ZS; Timofeev VV Vestn Khir Im I I Grek; 1970 Jun; 104(6):126-30. PubMed ID: 5489202 [No Abstract] [Full Text] [Related]
58. Management of hemorrhagic shock when blood is not an option. Mackenzie CF; Morrison C; Jaberi M; Genuit T; Katamuluwa S; Rodriguez A J Clin Anesth; 2008 Nov; 20(7):538-41. PubMed ID: 19019664 [TBL] [Abstract][Full Text] [Related]